Skip to main content

Formoterol News

Bevespi Aerosphere Approved by the FDA for Patients with COPD

25 April 2016 – AstraZeneca today announced that the US Food and Drug Administration has approved Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) inhalation aerosol indicated for the...

FDA Medwatch Alert: Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements

[UPDATED 04-15-2011] To further evaluate the safety of Long-Acting Beta-Agonists (LABAs) when used in combination with inhaled corticosteroids for the treatment of asthma, the FDA is requiring the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Asthma - Maintenance, Chronic Obstructive Pulmonary Disease

Formoterol patient information at Drugs.com